Zura Bio Ltd. Relocates Principal Executive Offices
Ticker: ZURA · Form: 8-K · Filed: Jun 14, 2024 · CIK: 1855644
| Field | Detail |
|---|---|
| Company | Zura Bio Ltd (ZURA) |
| Form Type | 8-K |
| Filed Date | Jun 14, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $11.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: administrative, corporate-action
TL;DR
Zura Bio moved its HQ to Henderson, NV. No major financial news, just an address change.
AI Summary
Zura Bio Ltd. filed an 8-K on June 14, 2024, reporting a change in its principal executive offices to Henderson, NV. The company, formerly JATT Acquisition Corp, was incorporated in the Cayman Islands and operates in the biological products sector.
Why It Matters
A change in principal executive offices can indicate operational shifts or strategic realignments within the company.
Risk Assessment
Risk Level: low — This filing solely reports a change in the company's principal executive office address, which is a routine administrative update.
Key Players & Entities
- Zura Bio Limited (company) — Registrant
- JATT Acquisition Corp (company) — Former company name
- Henderson, NV (location) — New principal executive offices
- Cayman Islands (location) — Jurisdiction of incorporation
FAQ
What is the new address for Zura Bio Ltd.'s principal executive offices?
The new address for Zura Bio Ltd.'s principal executive offices is 1489 W. Warm Springs Rd. #110, Henderson, NV 89014.
When was the report filed?
The report was filed on June 14, 2024.
What was Zura Bio Ltd.'s former company name?
Zura Bio Ltd.'s former company name was JATT Acquisition Corp.
In which jurisdiction was Zura Bio Ltd. incorporated?
Zura Bio Ltd. was incorporated in the Cayman Islands.
What is Zura Bio Ltd.'s Standard Industrial Classification code?
Zura Bio Ltd.'s Standard Industrial Classification code is 2836, for Biological Products (No Diagnostic Substances).
Filing Stats: 520 words · 2 min read · ~2 pages · Grade level 9.9 · Accepted 2024-06-14 06:04:41
Key Financial Figures
- $0.0001 — ed Class A Ordinary Shares, par value $0.0001 per share ZURA The Nasdaq Stock Mar
- $11.50 — Ordinary Share at an exercise price of $11.50 per share ZURAW The Nasdaq Stock Ma
Filing Documents
- tm24172501_8k.htm (8-K) — 31KB
- tm24172501_ex99-1.htm (EX-99.1) — 20KB
- tm24172501_ex99-1img001.jpg (GRAPHIC) — 5KB
- 0001104659-24-071445.txt ( ) — 280KB
- zura-20240614.xsd (EX-101.SCH) — 3KB
- zura-20240614_def.xml (EX-101.DEF) — 26KB
- zura-20240614_lab.xml (EX-101.LAB) — 36KB
- zura-20240614_pre.xml (EX-101.PRE) — 25KB
- tm24172501_8k_htm.xml (XML) — 5KB
01
Item 7.01. Regulation FD Disclosure. On June 14, 2024, Zura Bio Limited issued the press release attached hereto as Exhibit 99.1 to this Current Report on Form 8-K. The information set forth in this Item 7.01 is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the " Exchange Act "), or otherwise 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated June 14, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: June 14, 2024 ZURA BIO LIMITED By: /s/ Kim Davis Kim Davis Chief Legal Officer